Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation (Q24241083)

3

0 references

Anat Gafter-Gvili

2

0 references

Ofer Shpilberg

6

0 references

Pia Raanani

1

0 references

Isaac Ben-Bassat

Cochrane Database of Systematic Reviews

4

object named as

Isaac Ben-Bassat

0 references

publication date

8 October 2008

0 references

published in

0 references

cites work

Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Cytomegalovirus (CMV)-Specific Intravenous Immunoglobulin for the Prevention of Primary CMV Infection and Disease after Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Role of gamma globulin for immunoprophylaxis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Human Monoclonal Antibodies Neutralizing Cytomegalovirus (CMV) for Prophylaxis of CMV Disease: Report of a Phase I Trial in Bone Marrow Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Immunoglobulin administration as infection prevention in oncologic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

A Pilot Study Using Intravenous Immunoglobulin for the Prevention of Infection During Remission Induction in Acute Leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Pharmacokinetics of intravenous immunoglobulin (Gammagard) in bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Hypogammaglobulinaemia in chronic lymphatic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Intravenous immune globulin therapy in hypogammaglobulinemia. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

PREDICTING THE COSTS OF ALLOGENEIC SIBLING STEM-CELL TRANSPLANTATION: RESULTS FROM A PROSPECTIVE, MULTICENTER, FRENCH STUDY

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): kinetics of immunoglobulin metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Influence of treatment and response status on infection risk in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Prophylactic Intravenous Immunoglobulin Treatment Influences Serum Immunoglobulin M Repertoire Development after Allogeneic Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Cytomegalovirus infections after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Prophylaxis against infections with intravenous immunoglobulins in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Current patterns of bacterial infection in myelomatosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Agammaglobulinemia and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Biphasic pattern of bacterial infection in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

Cytomegalovirus Immune Plasma in Bone Marrow Transplant Recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006501.PUB2

7 January 2021

10.1002/14651858.CD006501.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18843719

1 reference

Consolidated OpenCitations Corpus – April 2017